Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29.1M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
20.3M
-
Shares change
-
+1.21M
-
Total reported value, excl. options
-
$1.35B
-
Value change
-
+$79.5M
-
Put/Call ratio
-
0.65
-
Number of buys
-
66
-
Number of sells
-
-67
-
Price
-
$66.54
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q1 2022
161 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q1 2022.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.3M shares
of 29.1M outstanding shares and own 69.96% of the company stock.
Largest 10 shareholders include FMR LLC (2.11M shares), Redmile Group, LLC (1.82M shares), Point72 Asset Management, L.P. (1.72M shares), BlackRock Inc. (1.68M shares), LORD, ABBETT & CO. LLC (1.18M shares), STATE STREET CORP (1.07M shares), VANGUARD GROUP INC (1.05M shares), Avoro Capital Advisors LLC (1.01M shares), Frazier Life Sciences Management, L.P. (866K shares), and BAKER BROS. ADVISORS LP (808K shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.